Welcome to our dedicated page for Nexgel Wt Exp 120126 news (Ticker: NXGLW), a resource for investors and traders seeking the latest updates and insights on Nexgel Wt Exp 120126 stock.
NexGel, Inc. reports company developments tied to its hydrogel-based healthcare, beauty, and over-the-counter product business. The company manufactures high-water-content, electron-beam cross-linked aqueous polymer hydrogels used in wound care, medical diagnostics, transdermal drug delivery and cosmetics, and its updates commonly cover operating results, product and technology applications, contract manufacturing, and consumer health and beauty activity.
Recurring news also includes material agreements, financing and capital-structure actions, shareholder voting matters, and corporate actions involving drug-delivery assets and regenerative biomaterial product opportunities. These announcements frame NexGel as an operating medical and consumer products company built around hydrogel manufacturing technologies.
NEXGEL reported a 35% year-over-year revenue growth to $561 thousand for Q2 2022, showing a 42% sequential increase. The rise is attributed to successful launches and demand for branded products, such as MEDAGEL Pro Pads. Gross profit improved to $101 thousand, with an 18% margin. However, operating expenses rose to $819 thousand, driven by increased R&D investments and higher SG&A costs. As of June 30, 2022, cash and equivalents stood at $9.7 million, ensuring a solid financial position for ongoing growth initiatives.
NEXGEL (NASDAQ: NXGL) will report its financial and operating results for Q2 2022 on August 10, 2022, after market close. Following the release, a conference call will be held at 4:30 P.M. ET the same day. Interested individuals can join the call via a U.S. toll-free number or international dial-in options, and a webcast will be available on the company’s Investor Relations website. A replay of the call will be accessible until August 17, 2022. NEXGEL specializes in high-water-content hydrogel products for healthcare and consumer applications.
NEXGEL (NASDAQ: NXGL, NXGLW) has launched the MEDAGEL Hydroliner Pro pads designed to protect eyelashes during cosmetic services like extensions and lifts. These pads offer a breathable, flexible, and skin-friendly alternative to traditional options, preventing slippage while being gentle on sensitive skin. They aim to enhance client comfort, allowing for easy removal and replacement during the application process. This product marks NEXGEL's first proprietary business-to-business offering, expanding its innovative hydrogel product line.
NEXGEL (NASDAQ: NXGL, NXGLW) has launched a partnership with Partners for World Health to provide humanitarian support in Ukraine. For every two boxes of SilverSeal® purchased, one will be donated to those in need. In June, 458 boxes were donated, equating to 1,832 healing patches. CEO Adam Levy emphasized the importance of treating skin injuries in crisis zones. The initiative addresses urgent medical needs amid ongoing conflict, aiming to deliver essential supplies through various shipping methods.